List of insiders holdings for Kaleido Biosciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship VentureLabs V LLC Flagship VentureLabs V Manager LLC Flagship Pioneering Inc. Nutritional Health Disruptive Innovation Fund L.P. Nutritional Health Side Fund L.P. Flagship Ventures Opportunities Fund I L.P. Flagship Ventures Opportunities Fund I General Partner LLC AFEYAN NOUBAR Director 10% Owner |
2021-02-10 17:15:56 | 19,575,710 0 |
19,575,710 | Form 13D |
| 2 | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. AFEYAN NOUBAR 10% Owner |
2021-02-10 17:30:18 | 0 14,907,627 |
14,907,627 | Form 4 |
| 3 | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship VentureLabs IV LLC Flagship Ventures 2007 General Partner LLC Flagship Ventures Fund 2007 L.P. Cadena LLC AFEYAN NOUBAR KANIA EDWIN M JR Director 10% Owner |
2019-03-06 16:43:12 | 0 2,682,840 |
2,682,840 | Form 4 |
| 4 | Menichella Daniel L Chief Executive Officer |
2022-01-18 17:09:32 | 320,200 0 |
320,200 | Form 4 |
| 5 | Long Alison S Chief Medical Officer |
2022-01-18 17:15:22 | 171,800 0 |
171,800 | Form 4 |
| 6 | Duke William E. Chief Financial Officer |
2022-01-18 17:11:18 | 169,990 0 |
169,990 | Form 4 |
| 7 | Lawton Alison Frances See Remarks |
2020-04-17 08:00:46 | 118,500 0 |
118,500 | Form 4 |
| 8 | Brumm Joshua T See Remarks |
2019-03-04 20:10:32 | 80,000 0 |
80,000 | Form 4 |
| 9 | Knobil Katharine Chief Medical Officer |
2020-10-19 07:38:03 | 67,500 0 |
67,500 | Form 4 |
| 10 | SCULLEY JOHN Director |
2019-02-27 18:21:58 | 50,000 0 |
50,000 | Form 3 |
| 11 | Scalzo Richard William Principal Accounting Officer |
2019-10-15 18:52:03 | 50,000 0 |
50,000 | Form 3 |
| 12 | McIntyre Jonathan Director |
2019-02-27 18:17:00 | 50,000 0 |
50,000 | Form 3 |
| 13 | BONNEY MICHAEL W Director |
2021-07-01 16:25:22 | 30,000 0 |
30,000 | Form 4 |
| 14 | Mixer Jean K Director |
2021-07-01 16:32:20 | 15,000 0 |
15,000 | Form 4 |
| 15 | MELAS KYRIAZI THEO Director |
2021-07-01 16:35:57 | 15,000 0 |
15,000 | Form 4 |
| 16 | Bassler Bonnie L Director |
2021-07-01 16:38:51 | 15,000 0 |
15,000 | Form 4 |
| 17 | Burnett Grady Director |
2021-07-01 16:42:47 | 15,000 0 |
15,000 | Form 4 |
| 18 | Prener Anne Director |
2021-07-01 16:28:15 | 15,000 0 |
15,000 | Form 4 |
| 19 | Quinn Anthony G. Director |
2021-07-01 16:22:33 | 15,000 0 |
15,000 | Form 4 |
| 20 | von Maltzahn Geoffrey Director |
2021-07-01 16:19:46 | 15,000 0 |
15,000 | Form 4 |
| 21 | van Hylckama Vlieg Johan Chief Scientific Officer |
2022-03-02 16:09:49 | 4,620 0 |
4,620 | Form 4 |
| 22 | Korn Jerald COO & General Counsel |
2022-03-02 16:05:37 | 4,517 0 |
4,517 | Form 4 |